---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-092566"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2023-08-16T23:59:59+00:00"
generated_at: "2026-06-11T08:29:01.154177+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics expands leased space by ~61k SF; annual rent ~$4.9M starting June 2024

## Summary
- Total leased premises grows to 93,449 rentable SF (from ~32k SF) with addition of third floor.
- Expansion rent commences June 2024 at $4,873,906.50 annual base rent, escalating ~3% annually through Jan 2031.
- Landlord provides up to $1,839,210 tenant improvement allowance; tenant covers excess costs.
- Security deposit letter of credit increased from ~$1.04M to ~$2.26M as of Jan 1, 2024.
- Parking allocated to tenant increases from 75 to 228 spaces upon expansion commencement.

## SEC filing metadata
- accession: 0001104659-23-092566
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2023-08-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465923092566/0001104659-23-092566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465923092566/tm2323892d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-092566
- JSON: https://secwatch.observer/filing/0001104659-23-092566.json
- Plain text: https://secwatch.observer/filing/0001104659-23-092566.txt

## Key facts
- Debt Financings
  Voyager Therapeutics, Inc. amended lease obligation of Annual base rent of approximately $4.9 million increasing annually by approximately 3%; total commitment of ~$2.3 millio with LS 75 Hayden, LLC at Not applicable (lease) maturing January 31, 2031.
  - Instrument: lease obligation
  - Principal: Annual base rent of approximately $4.9 million increasing annually by approximately 3%; total commitment of ~$2.3 millio
  - Counterparty: LS 75 Hayden, LLC
  - Rate: Not applicable (lease)
  - Maturity: January 31, 2031
  - Event: amendment
  source text: mendment”) to its existing lease agreement with LS 75 Hayden, LLC, as successor in interest to HCP/King 75 Hayden LLC (the “Landlord”),
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465923092566/0001104659-23-092566-index.htm
- Material Agreements
  Voyager Therapeutics, Inc. amended Lease Agreement with LS 75 Hayden, LLC (effective 2023-08-11).
  - Action: amendment
  - Agreement: lease
  - Counterparty: LS 75 Hayden, LLC
  - Effective: 2023-08-11
  source text: On August 11, 2023, Voyager Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a first amendment (the “First Amendment”) to its existing lease agreement with LS 75 Hayden, LLC, as successor in interest to HCP/King 75 Hayden LLC (the “Landlord”), dated March 16, 2020 (the “Lease Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465923092566/0001104659-23-092566-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.